Search - tctmd.com

Displaying 161 - 180 of 211

Sort: Relevancy | Date

News Daily News

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

Michael O'Riordan

October 05, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Conference News HFSA 2022

Dapagliflozin’s Benefits Similar in HF Patients With Improved EF: DELIVER

Todd Neale

October 04, 2022

Presentation TCT 2022

TCT 808: Cardiogenic Shock & Severe MR treated with NTW MitraClip: Bridge to stabilization - GDMT

Presenter: Carlos Requena-Armas

September 18, 2022

Presentation TCT 2022

Lessons from a Heart Failure Specialist: GDMT and Timing of TEER in SMR

Presenter: Sean Pinney

September 17, 2022

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

Presentation TCT 2022

Why Don’t You Just Clip It Now? The Role of GDMT in Procedural Timing

Presenter: Russell Brandwein

September 16, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2022

Shelley Wood

September 01, 2022

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Daily News

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

L.A. McKeown

June 21, 2022

Presentation TVT 2022

GDMT and Timing of TEER in SMR: Reconciling Guidelines With Clinical Realities

Presenter: Saibal Kar

June 10, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

Presentation TVT 2022

What Are the Indicators That GDMT Is Maximized in the Symptomatic Patient?

Presenter: Sean Pinney

June 09, 2022

Presentation TVT 2022

The “New” Heart Failure GDMT Guidelines “FOR DUMMIES”: What Every Structural Interventionalist Needs to Know

Presenter: Sean Pinney

June 09, 2022

News Daily News

Underuse of GDMT for Heart Failure Even Worse in Low-Income Countries

Todd Neale

April 20, 2022

News Conference News ACC 2022

DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF

L.A. McKeown

April 08, 2022

News Conference News ACC 2022

PROMPT-HF: Pop-up Alerts Improve HFrEF Medication Optimization

L.A. McKeown

April 03, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Shelley Wood

October 08, 2021

Advertisement

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Dapagliflozin’s Benefits Similar in HF Patients With Improved EF: DELIVER

TCT 808: Cardiogenic Shock & Severe MR treated with NTW MitraClip: Bridge to stabilization - GDMT

Lessons from a Heart Failure Specialist: GDMT and Timing of TEER in SMR

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Why Don’t You Just Clip It Now? The Role of GDMT in Procedural Timing

TCTMD’s Top 10 Most Popular Stories for August 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

GDMT and Timing of TEER in SMR: Reconciling Guidelines With Clinical Realities

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

What Are the Indicators That GDMT Is Maximized in the Symptomatic Patient?

The “New” Heart Failure GDMT Guidelines “FOR DUMMIES”: What Every Structural Interventionalist Needs to Know

Underuse of GDMT for Heart Failure Even Worse in Low-Income Countries

DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF

PROMPT-HF: Pop-up Alerts Improve HFrEF Medication Optimization

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Guideline-Directed Therapies Underused in Frail HF Patients

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content